{
    "Trade/Device Name(s)": [
        "BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K090971",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081825",
        "K043144"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "June 5, 2009",
    "Summary Letter Received Date": "April 6, 2009",
    "Submission Date": "April 3, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Female endocervical swab",
        "Male urethral swab",
        "Vaginal swab",
        "Female urine",
        "Male urine"
    ],
    "Specimen Container(s)": [
        "Extraction Tube",
        "Microwell"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Nucleic acid amplification",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "DNA amplification",
        "DNA probe",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay using SDA technology for detection of Neisseria gonorrhoeae DNA",
    "Indications for Use Summary": "Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swabs, patient-collected vaginal swabs, and female/male urine specimens to aid in diagnosis of gonococcal urogenital disease in symptomatic and asymptomatic individuals",
    "fda_folder": "Microbiology"
}